Login
$ATII
$9.81 +$2.64 (36.82%) Close

Consolidated Balance Sheets (Current Period Unaudited)

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Deferred offering costs
Current assets
Cash
Prepaid expenses
Total current assets
Deferred offering costs
Prepaid insurance
Demand deposit held in Trust Account
TOTAL ASSETS
Current liabilities
Accrued expenses
Accrued offering costs
Due to related party
Promissory note – related party
Related Party
Total promissory note – related party
PIPE subscription derivative liability
Total current liabilities
Deferred underwriting fee payable
TOTAL LIABILITIES
Ordinary shares subject to possible redemption, 23,000,000 shares at redemption value of $10.62 and $10.43 per share as of June 30, 2026 and December 31, 2025, respectively
SHAREHOLDERS’ DEFICIT
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Ordinary shares, $0.0001 par value; 400,000,000 shares authorized; 6,590,000 shares issued and outstanding (excluding 23,000,000 shares subject to possible redemption) as of June 30, 2026 and December 31, 2025
Additional paid-in capital
Accumulated deficit
TOTAL SHAREHOLDERS’ DEFICIT
TOTAL LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support